Wages, Nolan A. http://orcid.org/0000-0002-2190-4864
Slingluff, Craig L. Jr.
Bullock, Timothy N.
Petroni, Gina R.
Funding for this research was provided by:
National Cancer Institute (K25CA181638, R01CA142859)
Melanoma Research Alliance (Team Science Award, Team Science Award)
Article History
Received: 29 January 2019
Accepted: 27 November 2019
First Online: 5 December 2019
Compliance with ethical standards
:
: Dr. Slingluff is an inventor on patents of peptides for use in clinical trials of cancer vaccines; these patents are held by the University of Virginia Licensing and Ventures Group. He also is on and the University receives funding for his roles as external advisory board member for Immatics, CureVac., and as PI for a clinical trial of a cell-based vaccine sponsored by Polynoma. He also receives support for investigator-sponsored cancer immunotherapy clinical trials from GlaxoSmithKline, Celldex, 3 M, and Merck. All remaining authors have declared no conflicts of interest.
: This article does not contain any studies with human participants performed by any of the authors.
: This article does not contain any studies with human participants performed by any of the authors.